1. Home
  2. HRZN vs MOBI Comparison

HRZN vs MOBI Comparison

Compare HRZN & MOBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Horizon Technology Finance Corporation

HRZN

Horizon Technology Finance Corporation

HOLD

Current Price

$4.67

Market Cap

322.2M

Sector

Finance

ML Signal

HOLD

MOBI

Mobia Medical Inc. Common Stock

N/A

Current Price

$11.89

Market Cap

366.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HRZN
MOBI
Founded
2008
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
322.2M
366.1M
IPO Year
N/A
2026

Fundamental Metrics

Financial Performance
Metric
HRZN
MOBI
Price
$4.67
$11.89
Analyst Decision
Hold
Analyst Count
5
0
Target Price
$6.50
N/A
AVG Volume (30 Days)
636.6K
108.7K
Earning Date
05-05-2026
N/A
Dividend Yield
33.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.25
N/A
Revenue Next Year
$22.53
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.80
$10.79
52 Week High
$8.46
$15.19

Technical Indicators

Market Signals
Indicator
HRZN
MOBI
Relative Strength Index (RSI) 57.03 41.38
Support Level $4.56 $10.79
Resistance Level $4.74 $13.88
Average True Range (ATR) 0.11 1.07
MACD 0.00 -0.14
Stochastic Oscillator 48.44 27.50

Price Performance

Historical Comparison
HRZN
MOBI

About HRZN Horizon Technology Finance Corporation

Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.

About MOBI Mobia Medical Inc. Common Stock

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.

Share on Social Networks: